These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10229541)

  • 1. Conformational changes in the hepatitis A virus capsid in response to acidic conditions.
    Bishop NE
    J Med Microbiol; 1999 May; 48(5):443-450. PubMed ID: 10229541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low pH on the hepatitis A virus maturation cleavage.
    Bishop NE
    Acta Virol; 1999 Oct; 43(5):291-6. PubMed ID: 10757229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis A virus replication: an intermediate in the uncoating process.
    Bishop NE
    Intervirology; 2000; 43(1):36-47. PubMed ID: 10773736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis A virus subviral particles: purification, accumulation, and relative infectivity of virions, provirions and procapsids.
    Bishop NE; Anderson DA
    Arch Virol; 1997; 142(11):2147-60. PubMed ID: 9672583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious hepatitis A virus particles produced in cell culture consist of three distinct types with different buoyant densities in CsCl.
    Lemon SM; Jansen RW; Newbold JE
    J Virol; 1985 Apr; 54(1):78-85. PubMed ID: 2983123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-dependent cleavage of VP0 capsid protein in provirions of hepatitis A virus.
    Bishop NE; Anderson DA
    Virology; 1993 Dec; 197(2):616-23. PubMed ID: 8249284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncoating kinetics of hepatitis A virus virions and provirions.
    Bishop NE; Anderson DA
    J Virol; 2000 Apr; 74(7):3423-6. PubMed ID: 10708462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of potential inhibitors of hepatitis A virus uncoating.
    Bishop NE
    Intervirology; 1998; 41(6):261-71. PubMed ID: 10325536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts.
    Martin A; Escriou N; Chao SF; Girard M; Lemon SM; Wychowski C
    Virology; 1995 Oct; 213(1):213-22. PubMed ID: 7483265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-dependent solubility shift of rubella virus capsid protein.
    Mauracher CA; Gillam S; Shukin R; Tingle AJ
    Virology; 1991 Apr; 181(2):773-7. PubMed ID: 2014651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational behavior of the HAV-VP3(110-121) peptidic sequence and synthetic analogs in membrane environments studied by CD and computational methods.
    Pérez JA; Cantó J; Reig F; Pérez JJ; Haro I
    Biopolymers; 1998 Jun; 45(7):479-92. PubMed ID: 9577229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of incomplete hepatitis A virus particles.
    Ruchti F; Siegl G; Weitz M
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2159-66. PubMed ID: 1654375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of hepatitis A virus.
    Siegl G; Weitz M; Kronauer G
    Intervirology; 1984; 22(4):218-26. PubMed ID: 6096294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction study of peptide from VP3 capsid protein of hepatitis A virus through monolayers and fluorescence spectroscopy.
    Sospedra P; Prat J; Haro I; Mestres C; Busquets MA
    Luminescence; 2001; 16(2):103-7. PubMed ID: 11312535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of a hepatitis A virus candidate vaccine strain.
    Heinricy U; Stierhof YD; Pfisterer M; Flehmig B
    J Gen Virol; 1987 Sep; 68 ( Pt 9)():2487-93. PubMed ID: 2821186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early interactions of hepatitis A virus with cultured cells: viral elution and the effect of pH and calcium ions.
    Bishop NE; Anderson DA
    Arch Virol; 1997; 142(11):2161-78. PubMed ID: 9672584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, lipophilic derivatization and interaction with liposomes of HAV-VP3 (102-121) sequence by using spectroscopic techniques.
    Garcia M; Pujol M; Reig F; Alsina MA; Haro I
    Analyst; 1996 Nov; 121(11):1583-8. PubMed ID: 8952449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategy for nonenveloped virus entry: a hydrophobic conformer of the reovirus membrane penetration protein micro 1 mediates membrane disruption.
    Chandran K; Farsetta DL; Nibert ML
    J Virol; 2002 Oct; 76(19):9920-33. PubMed ID: 12208969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural studies of adeno-associated virus serotype 8 capsid transitions associated with endosomal trafficking.
    Nam HJ; Gurda BL; McKenna R; Potter M; Byrne B; Salganik M; Muzyczka N; Agbandje-McKenna M
    J Virol; 2011 Nov; 85(22):11791-9. PubMed ID: 21900159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assembly, stability and dynamics of virus capsids.
    Mateu MG
    Arch Biochem Biophys; 2013 Mar; 531(1-2):65-79. PubMed ID: 23142681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.